News
Ventyx Biosciences has shared phase 2a data on a Parkinson’s disease prospect that has caught the eye of Sanofi. The readout shows the effect of VTX3232 on biomarkers, providing some of the data that ...
Nielsen, who was diagnosed with MS aged 17, addressed NHS healthcare professionals, local government members and those in the ...
Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million ...
Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million fixed-rate notes, due June 2029, bearing interest at an ...
French pharmaceutical giant Sanofi announced on Tuesday that Tzield, the world's first and only therapy approved by the ...
The National Agency for Food and Drugs Administration and Control has alerted the public to the discovery of an unregistered batch of Tarivid 200mg in ...
Explore more
1dOpinion
Zacks Investment Research on MSN5 Large Drug Stocks That Are Poised to Ride on Sector RecoveryThe sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...
Sanofi (NASDAQ: SNY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Berenberg Bank analyst Luisa Hector ...
On June 9, Regeneron Pharmaceuticals and Sanofi (NASDAQ:SNY) announced promising interim results from the open-label Phase 4 ...
After 25 years developing vaccines with French drugmaker Sanofi, Sanjay Gurunathan, M.D., has departed for GSK. Gurunathan ...
Lina Nielsen has vowed to spend the rest of her life campaigning for greater awareness of multiple sclerosis after speaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results